To send appointment requests to presenters, please click
At Academic Forum, researchers of universities and national/public
institutes will present their latest research results.

Venue : Inside the Exhibition Halls (no pre-registration necessary.)
*Please note that some forum may not have interpretation.
(Honorifics omitted) *Please note that programs are subject to change.
*Any photography, filming or audio/video recording is strictly prohibited during all session.
Date:May 11 (Wed) 12:15 ~ 12:45     Venue: ACA-1
『Application development of a new super cooling preservation method using the natural material』
Date:May 11 (Wed) 12:15 ~ 12:45     Venue: ACA-3
『Activities and prospects of National Center Biobank Network』
Date:May 11 (Wed) 12:15 ~ 12:45     Venue: ACA-2
『Development of drug discovery technologies and approach for drug discovery support』
Date:May 11 (Wed) 12:15 ~ 12:45     Venue: ACA-5
『Mechanism underlying cell death in B cell lymphomas by anti-HLA-DR Antibody』
Date:May 11 (Wed) 12:15 ~ 12:45     Venue: ACA-4
『Development of detective and diagnostic pharmaceuticals for infectious disease and cancer (II)』
Date:May 11 (Wed) 12:15 ~ 12:45     Venue: ACA-6
『New bioanalytical methods for therapeutic monoclonal antibodies 』
Date:May 11 (Wed) 13:00 ~ 13:30     Venue: ACA-3
『Development of a new method for testing mutagenicity using modified fluorescence protein genes』
Date:May 11 (Wed) 13:00 ~ 13:30     Venue: ACA-4
『In silico drug discovery with FAMS and chooseLD』
Date:May 11 (Wed) 13:00 ~ 13:30     Venue: ACA-1
『Novel Assisted Reproductive Technology in Domesticated Animals by Mesenchymal Stem Cells』
Date:May 11 (Wed) 13:00 ~ 13:30     Venue: ACA-5
『New tumor model with stemness and iron control therapy for cancer stem cell』
Date:May 11 (Wed) 13:00 ~ 13:30     Venue: ACA-2
『Discovery of myokines as pills that mimic the health benefits of exercise.』
Date:May 11 (Wed) 13:00 ~ 13:30     Venue: ACA-6
『Multi biomarker detection using semiconductor MEMS technology』
Date:May 11 (Wed) 14:30 ~ 15:00     Venue: ACA-5
『Strategy of RNA-interference medicine for cancer driver gene』
Date:May 11 (Wed) 14:30 ~ 15:00     Venue: ACA-2
『Development of Drosophila model for human CMT』
Date:May 11 (Wed) 14:30 ~ 15:00     Venue: ACA-6
『Development of immunochromatography to detect drug resistance bacteria producing ArmA 』
Date:May 11 (Wed) 14:30 ~ 15:00     Venue: ACA-1
『Effective procedure to produce iPS cells』
Date:May 11 (Wed) 14:30 ~ 15:00     Venue: ACA-4
『Okayama University Hospital Biobank (Okadai Biobank)』
Date:May 11 (Wed) 14:30 ~ 15:00     Venue: ACA-3
『Methods of crystallization and crystal polymorphism for difficulty crystallization samples』
Date:May 11 (Wed) 15:15 ~ 15:45     Venue: ACA-4
『Development of a novel anti-retinal neovascular therapy targeting HB-EGF』
Date:May 11 (Wed) 15:15 ~ 15:45     Venue: ACA-2
『Construction of in vitro and in vivo HBV replication models for estimating antiviral effects』
Date:May 11 (Wed) 15:15 ~ 15:45     Venue: ACA-5
『Spontaneous colitis and colorectal adenoma in T cell-specific Rap1-deficient mice』
Date:May 11 (Wed) 15:15 ~ 15:45     Venue: ACA-1
『Application of Quantum Beam Science and Technology for Life Innovation』
Date:May 11 (Wed) 15:15 ~ 15:45     Venue: ACA-3
『Optimized enzyme-substrate pair for cell ELISA system for the exploration of functional antibody』
Date:May 11 (Wed) 15:15 ~ 15:45     Venue: ACA-6
『Overview and Perspective in Next Generation Healthcare Devices』
Date:May 11 (Wed) 16:00 ~ 16:30     Venue: ACA-4
『Exploring novel therapeutic target that controls NO-induced TLR4 signaling in ulcerative colitis』
Date:May 11 (Wed) 16:00 ~ 16:30     Venue: ACA-6
『Brand-new Realization and Medical Development of Softness Sensor with Various Functions』
Date:May 11 (Wed) 16:00 ~ 16:30     Venue: ACA-5
『IL-20 antibody is a potential drug for diseases』
Date:May 11 (Wed) 16:00 ~ 16:30     Venue: ACA-2
『Artificial openable intestinal tract for in vitro medicine evaluation system by using cultured cells』
Date:May 11 (Wed) 16:00 ~ 16:30     Venue: ACA-1
『Chitin nanofibers from crab shell: preparation and the applications for health care』
Date:May 11 (Wed) 16:45 ~ 17:15     Venue: ACA-5
『Multi-target and less toxic curcumin analog to suppress epithelial cancers by its topical usage』
Date:May 11 (Wed) 16:45 ~ 17:15     Venue: ACA-3
『Novel method to construct 3-D cellular assembly: Non-invasive processing by use of laser』
Date:May 11 (Wed) 16:45 ~ 17:15     Venue: ACA-2
『Contamination-free whole genome amplification toward gene screening from scarce and unknown bacteria』
Date:May 11 (Wed) 16:45 ~ 17:15     Venue: ACA-4
『Development of diagnostic markers of autoimmune diseases based on protein modification alteration』
Date:May 11 (Wed) 16:45 ~ 17:15     Venue: ACA-6
『Evaluation system of human healthy by its microbiome』
Date:May 11 (Wed) 16:45 ~ 17:15     Venue: ACA-1
『Characterization of bio-active factors acting on health and youth--Longevity Genes and Health--』
Date:May 12 (Thur) 10:45 ~ 11:15     Venue: ACA-6
『Biological Membrane Devices for Drug Screening and Sensor Applications』
Date:May 12 (Thur) 10:45 ~ 11:15     Venue: ACA-2
『Ultra micro exploring screening for pharmaceutical cocrystals』
Date:May 12 (Thur) 10:45 ~ 11:15     Venue: ACA-4
『Adamantyl vitamin D compounds are possible drug candidates for the treatment of osteoporosis』
Date:May 12 (Thur) 10:45 ~ 11:15     Venue: ACA-3
『Peptide Tags That can Control Association and The application to the non-column protein purification』
Date:May 12 (Thur) 10:45 ~ 11:15     Venue: ACA-1
『Tailor-made inorganic nanocrystals towards bio-medical applications』
Date:May 12 (Thur) 10:45 ~ 11:15     Venue: ACA-5
『Realizing the personalized cancer medicine by a novel discrete Bayes decision theory』
Date:May 12 (Thur) 11:30 ~ 12:00     Venue: ACA-5
『Our original m-CRA (viro-gene-therapy) for clinical trial and the innovative anticancer medicine』
Date:May 12 (Thur) 11:30 ~ 12:00     Venue: ACA-2
『"Kitasato Microbial Library" as Drug Discovery Resources』
Date:May 12 (Thur) 11:30 ~ 12:00     Venue: ACA-4
『Development of anti-infective agent without bactericidal action』
Date:May 12 (Thur) 11:30 ~ 12:00     Venue: ACA-3
『Cell-Free Transcription and Translation System realizing cyclopedic protein synthesis.』
Date:May 12 (Thur) 11:30 ~ 12:00     Venue: ACA-6
『Biomedical materials by multi-functionalization of polylactides and poly(trimethylene carbonate)』
Date:May 12 (Thur) 11:30 ~ 12:00     Venue: ACA-1
『Development of controlling selective microbes using microbial membrane vesicles』
Date:May 12 (Thur) 12:15 ~ 12:45     Venue: ACA-4
『The development of colon cancer treatment method by maple syrup』
Date:May 12 (Thur) 12:15 ~ 12:45     Venue: ACA-2
『"Kitasato Compound Library" as Drug seeds』
Date:May 12 (Thur) 12:15 ~ 12:45     Venue: ACA-3
『Non-cleaving genome editing technology』
Date:May 12 (Thur) 12:15 ~ 12:45     Venue: ACA-6
『Development of novel diagnostic system and therapy for periodontitis』
Date:May 12 (Thur) 12:15 ~ 12:45     Venue: ACA-5
『Introduction to the Cancer Stem Cell Collection from iPSCs and the prospects for cancer therapy』
Date:May 12 (Thur) 12:15 ~ 12:45     Venue: ACA-1
『Development of Asymmetric Pudovik Reaction Using Novel Organocatalyst』
Date:May 12 (Thur) 13:45 ~ 14:15     Venue: ACA-1
『Evaluation for impacts of chemical substances using an oral administration technique to neonatal rat』
Date:May 12 (Thur) 13:45 ~ 14:15     Venue: ACA-5
『Evaluation of drug-metabolizing enzyme in cancer 3D spheroid.』
Date:May 12 (Thur) 13:45 ~ 14:15     Venue: ACA-6
『Development about Photochemical DNA and RNA manipulation』
Date:May 12 (Thur) 13:45 ~ 14:15     Venue: ACA-2
『Development of fullerene derivatives for photodynamic therapy』
Date:May 12 (Thur) 13:45 ~ 14:15     Venue: ACA-4
『Developping rapid detection method for multidurug-resistant ESBL by mass spectrometry』
Date:May 12 (Thur) 13:45 ~ 14:15     Venue: ACA-3
『Applications of insect virus-derived protein micro-crystals on protein containers』
Date:May 12 (Thur) 14:30 ~ 15:00     Venue: ACA-5
『Novel anti-tumor drug using lactobacillus-derived ferrichrome』
Date:May 12 (Thur) 14:30 ~ 15:00     Venue: ACA-4
『Molecularly imprinted DDS nanocarriers that acquire stealth in situ』
Date:May 12 (Thur) 14:30 ~ 15:00     Venue: ACA-6
『Biomarker and application of proper use of ESA in renal disease therapy.』
Date:May 12 (Thur) 14:30 ~ 15:00     Venue: ACA-1
『Morphological profiling-based cell quality control in cell manufacturing』
Date:May 12 (Thur) 14:30 ~ 15:00     Venue: ACA-3
『Retinoid X receptor ligand screening system for drug or functional food discovery』
Date:May 12 (Thur) 14:30 ~ 15:00     Venue: ACA-2
『Identification of epigenetic drug targets using locus-specific chromatin immunoprecipitation』
Date:May 12 (Thur) 15:15 ~ 15:45     Venue: ACA-2
『Advanced generation of super monoclonal antibodies based on next generation of hybridoma technology』
Date:May 12 (Thur) 15:15 ~ 15:45     Venue: ACA-3
『Utilizing method of FIB-SEM &TEM for observation of the biological system sample』
Date:May 12 (Thur) 15:15 ~ 15:45     Venue: ACA-4
『Application of TAZ activator for therapy for sarcopenia』
Date:May 12 (Thur) 15:15 ~ 15:45     Venue: ACA-6
『Development of ultra-high-strength 1GPa pure Ti』
Date:May 12 (Thur) 16:00 ~ 16:30     Venue: ACA-3
『Development of a portable fluorescent microscopy for on-site bioassay』
Date:May 12 (Thur) 16:00 ~ 16:30     Venue: ACA-2
『Next Generation Zebrafish-Based Drug Discovery and Personalized Medicine』
Date:May 12 (Thur) 16:00 ~ 16:30     Venue: ACA-5
『Cancer treatment with recombinant anaerobic bacteria』
Date:May 12 (Thur) 16:00 ~ 16:30     Venue: ACA-6
『Non-intrusive In-Bed Monitoring Using Fabric Sheet Electrode』
Date:May 12 (Thur) 16:00 ~ 16:30     Venue: ACA-1
『Primary cell culture systems and functional bioassays for skeletal muscle regenerative medicine』
Date:May 12 (Thur) 16:00 ~ 16:30     Venue: ACA-4
『Edaravone as a scavenger of peroxynitrite』
Date:May 12 (Thur) 16:45 ~ 17:15     Venue: ACA-4
『In vivo retinal hypoxia imaging for diabetic retinopathy and macular degeneration』
Date:May 12 (Thur) 16:45 ~ 17:15     Venue: ACA-1
『1)Vector technology eradicating iPS-derived tumorigenic cells 2)HB-EGF medicine for liver diseases』
Date:May 12 (Thur) 16:45 ~ 17:15     Venue: ACA-3
『Data integration and computational network biology for drug discovery and development』
Date:May 12 (Thur) 16:45 ~ 17:15     Venue: ACA-2
『Production of active human membrane progesterone receptor (mPR)』
Date:May 12 (Thur) 16:45 ~ 17:15     Venue: ACA-5
『Transcription factor "Z" enhances cancer malignancy and drug resistance』
Date:May 12 (Thur) 16:45 ~ 17:15     Venue: ACA-6
『High contrast fluorescence imaging using an optical interference mirror slide』
Date:May 13 (Fri) 11:00 ~ 11:30     Venue: ACA-6
『CAD systems based on machine learning for colorectal and gastrointestinal endoscopic images』
Date:May 13 (Fri) 11:00 ~ 11:30     Venue: ACA-4
『 Application to the DDS of the opening/closing controllable protein nanocapsule』
Date:May 13 (Fri) 11:00 ~ 11:30     Venue: ACA-2
『Discovery of drugs for fibrodysplasia ossificans progressive: FOP from microbial origin.』
Date:May 13 (Fri) 11:00 ~ 11:30     Venue: ACA-5
『Immunotherapy targeting melanoma using whitening cosmetics rhododenol』
Date:May 13 (Fri) 11:00 ~ 11:30     Venue: ACA-3
『Development of a fluorescence-based assay for urate transport analysis』
Date:May 13 (Fri) 11:00 ~ 11:30     Venue: ACA-1
『How do we use quasi-drugs for improvement of androgenetic alopecia?』
Date:May 13 (Fri) 11:45 ~ 12:15     Venue: ACA-6
『Moving-mask Lithography Based Microfabrication for Micro Medical Device Development』
Date:May 13 (Fri) 11:45 ~ 12:15     Venue: ACA-3
『Technology to control protein activity using avidin-biotin binding』
Date:May 13 (Fri) 11:45 ~ 12:15     Venue: ACA-1
『Biomimetic design of bacterial membrane attacking antimicrobial agents』
Date:May 13 (Fri) 11:45 ~ 12:15     Venue: ACA-2
『A novel drug screening method using in vitro neural migration assay.』
Date:May 13 (Fri) 11:45 ~ 12:15     Venue: ACA-4
『Efects of chemokines in milk on growth and development of immune function in infants.』
Date:May 13 (Fri) 11:45 ~ 12:15     Venue: ACA-5
『Screening of artificial shRNA for the development of RNAi-based drug』
Date:May 13 (Fri) 12:30 ~ 13:00     Venue: ACA-4
『Genetic diagnosis methods for broad detection of diverse H5 subtype avian influenza viruses』
Date:May 13 (Fri) 12:30 ~ 13:00     Venue: ACA-3
『A novel fluorescent compound that emits light only under weakly acidic condition』
Date:May 13 (Fri) 12:30 ~ 13:00     Venue: ACA-5
『Development of Robot for CT-guided IR: Free physicians from Radiation』
Date:May 13 (Fri) 12:30 ~ 13:00     Venue: ACA-2
『Research cord Blood Bank for Medical develapment』
Date:May 13 (Fri) 12:30 ~ 13:00     Venue: ACA-1
『Contraction induces muscle glucose transport comparable to insulin action but by distinct mechanisms』
Date:May 13 (Fri) 12:30 ~ 13:00     Venue: ACA-6
『Determination of 5-FU-metabolizing activity of dihydropyrimidine dehydrogenase by LC-MS/MS』
Date:May 13 (Fri) 13:15 ~ 13:45     Venue: ACA-5
『Novel gene Susd2 inhibits growth of tumor cells by preferentially targeting cancer stem cells』
Date:May 13 (Fri) 13:15 ~ 13:45     Venue: ACA-2
『Photoresponsive Cell Migration Assay』
Date:May 13 (Fri) 13:15 ~ 13:45     Venue: ACA-3
『Peptide display and electrophysiological techniques for ion channel drug discovery』
Date:May 13 (Fri) 13:15 ~ 13:45     Venue: ACA-4
『New anti-inflammatory agent based on a new mechanism』
Date:May 13 (Fri) 13:15 ~ 13:45     Venue: ACA-6
『Development of Bubbles for Ultrasound Theranostics (Diagnostics and Therapeutics)』
Date:May 13 (Fri) 14:00 ~ 14:30     Venue: ACA-4
『Synthesis of Benzene-Glycol Nucleic Acids and their Biophysical and Biological Properties』
Date:May 13 (Fri) 14:00 ~ 14:30     Venue: ACA-6
『Rapid diagnosis determining quality & quantity of virus particles by NanoSuit method』
Date:May 13 (Fri) 14:00 ~ 14:30     Venue: ACA-1
『Establishment of a novel bioassay system to identify useful biological materials using Drosophila』
Date:May 13 (Fri) 14:00 ~ 14:30     Venue: ACA-2
『Introduction of the library of medicinal plant extracts for drug discovery』
Date:May 13 (Fri) 14:00 ~ 14:30     Venue: ACA-5
『Nano-pathophysiology: Intractability due to structure of disease foci limiting drug delivery』
Date:May 13 (Fri) 14:00 ~ 14:30     Venue: ACA-3
『Innovation of in vivo imaging system by artificial firefly luciferin-luciferase』
Date:May 13 (Fri) 14:45 ~ 15:15     Venue: ACA-1
『Development of retinal regenerative agent, Granulin』
Date:May 13 (Fri) 14:45 ~ 15:15     Venue: ACA-5
『Synthesis of bioactive compound bearing hydantoin structure』
Date:May 13 (Fri) 14:45 ~ 15:15     Venue: ACA-3
『Development of lifescience reagents derived from paralytic shellfish toxins』
Date:May 13 (Fri) 14:45 ~ 15:15     Venue: ACA-6
『Commercialization of a new fluorescent dye to the medical diagnostic technology』
Date:May 13 (Fri) 14:45 ~ 15:15     Venue: ACA-4
『Toward controlled drug delivery by tight-junction regulation using novel compounds 』
Date:May 13 (Fri) 14:45 ~ 15:15     Venue: ACA-2
『A vector system for single-cell labeling and labeled cell-specific gene manipulation』
Date:May 13 (Fri) 15:30 ~ 16:00     Venue: ACA-2
『IR/MAR gene amplification technology in mammalian cells, and its application to recombinant protein production』
Date:May 13 (Fri) 15:30 ~ 16:00     Venue: ACA-3
『Protein crystallization within a living cell』
Date:May 13 (Fri) 15:30 ~ 16:00     Venue: ACA-5
『Quality control of immune effector cells using a novel non-radioactive cellular cytotoxicity assay』
Date:May 13 (Fri) 15:30 ~ 16:00     Venue: ACA-6
『Introduction of National Institute of Genetics』
Date:May 13 (Fri) 15:30 ~ 16:00     Venue: ACA-1
『Regenerative medicine using dedifferentiated fat (DFAT) cells』
Date:May 13 (Fri) 15:30 ~ 16:00     Venue: ACA-4
『Activities for academia originated drug discovery by RIKEN』
▲PAGE UP